Should I buy or sell Dyadic International stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Dyadic International in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" DYAI shares. View DYAI analyst ratings or view top-rated stocks .

What is Dyadic International's stock price target for 2024?

1 equities research analysts have issued 12-month price targets for Dyadic International's shares. Their DYAI share price targets range from $6.00 to $6.00. On average, they anticipate the company's stock price to reach $6.00 in the next year. This suggests a possible upside of 257.1% from the stock's current price. View analysts price targets for DYAI or view top-rated stocks among Wall Street analysts .

How have DYAI shares performed in 2024?

Dyadic International's stock was trading at $1.61 at the start of the year. Since then, DYAI stock has increased by 4.3% and is now trading at $1.68. View the best growth stocks for 2024 here .

When is Dyadic International's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024. View our DYAI earnings forecast .

How were Dyadic International's earnings last quarter?

Dyadic International, Inc. (NASDAQ:DYAI) issued its quarterly earnings data on Wednesday, November, 10th. The biotechnology company reported ($0.06) EPS for the quarter, beating analysts' consensus estimates of ($0.09) by $0.03. The biotechnology company earned $0.69 million during the quarter, compared to analyst estimates of $0.61 million. Dyadic International had a negative trailing twelve-month return on equity of 81.57% and a negative net margin of 234.39%. During the same period last year, the firm earned ($0.09) EPS.

What other stocks do shareholders of Dyadic International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Dyadic International investors own include Silvercorp Metals (SVM) , Endeavour Silver (EXK) , Hecla Mining (HL) , Pfizer (PFE) , Advanced Micro Devices (AMD) , Endeavour Silver (EDR) , Mandalay Resources (MND) , Alibaba Group (BABA) and Chimerix (CMRX) .

How do I buy shares of Dyadic International?

Shares of DYAI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:DYAI

Dyadic International (DYAI) Stock Price, News & Analysis

→ Top 5 AI Stocks to Buy for 2024 (From Market Moving Trends) (Ad)

Free DYAI Stock Alerts

$1.68

-0.12 (-6.67%)

(As of 04/17/2024 ET)

Compare

Today's Range: $1.65
▼
$1.76
50-Day Range: $1.29
▼
$1.87
52-Week Range: $1.19
▼
$2.40

Volume: 16,514 shs
Average Volume: 22,361 shs
Market Capitalization: $48.67 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $6.00

Get Dyadic International alerts:

Dyadic International MarketRank™ Stock Analysis

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 257.1% Upside
$6.00 Price Target
Short Interest: Healthy
0.90% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: N/A
Insider Trading: N/A
Proj. Earnings Growth: Decreasing
From ($0.44) to ($0.90) Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.19 out of 5 stars

Medical Sector

539th out of 913 stocks

Biological Products, Except Diagnostic Industry

76th out of 134 stocks

3.5

Analyst's Opinion

Consensus Rating
Dyadic International has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.
Amount of Analyst Coverage
Dyadic International has received no research coverage in the past 90 days.

3.0

Short Interest

Percentage of Shares Shorted
0.90% of the float of Dyadic International has been sold short.
Short Interest Ratio / Days to Cover
Dyadic International has a short interest ratio ("days to cover") of 7.7.
Change versus previous month
Short interest in Dyadic International has recently decreased by 2.47%, indicating that investor sentiment is improving.

0.0

Dividend Strength

Dividend Yield
Dyadic International does not currently pay a dividend.
Dividend Growth
Dyadic International does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for DYAI.

0.6

News and Social Media Coverage

Search Interest
Only 2 people have searched for DYAI on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days.
MarketBeat Follows
1 people have added Dyadic International to their MarketBeat watchlist in the last 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Dyadic International insiders have not sold or bought any company stock.
Percentage Held by Insiders
27.30% of the stock of Dyadic International is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
Only 27.95% of the stock of Dyadic International is held by institutions.

0.0

Earnings and Valuation

Earnings Growth
Earnings for Dyadic International are expected to decrease in the coming year, from ($0.44) to ($0.90) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Dyadic International is -7.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Dyadic International is -7.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Dyadic International has a P/B Ratio of 8.40. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad Market Moving Trends

Top 5 AI Stocks to Buy for 2024

5 Best AI Stocks to Invest In Investors are getting very rich in AI stocks right now. Wall Street legend is giving away the name and ticker of the little-known AI stock Wall Street is currently buying hand-over-fist.

Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"

About Dyadic International Stock (NASDAQ:DYAI)

Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. It utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vaccines and drugs, such as virus-like particles, protein antigens, ferritin nanoparticles, monoclonal antibodies, bi/tri-specific antibodies, fab antibody fragments, Fc-fusion proteins, biosimilars and/or biobetters, and other therapeutic enzymes and proteins. The company offers DYAI-100, SARS-CoV-2-RBD antigen vaccine candidate towards a first-in-human Phase 1 clinical trial, is to demonstrate the safety in humans of a protein produced from C1-cell protein production platform. It has a research and development agreement with VTT Technical Research Centre of Finland, Ltd.; and strategic research services agreement with Biotechnology Developments for Industry in Pharmaceuticals, S.L.U., as well as co-development and marketing agreement with Fermbox Bio Inc to design,Develop, and commercialize animal free alternative proteins and biomaterials The company was founded in 1979 and is headquartered in Jupiter, Florida.

DYAI Stock Price History

30 days | 90 days | 365 days | Advanced Chart

DYAI Stock News Headlines

April 1, 2024 | msn.com

DYAI: Capital Raise to Accelerate Near Term Revenue Growth

April 1, 2024 | insidermonkey.com

Dyadic International, Inc. (NASDAQ:DYAI) Q4 2023 Earnings Call Transcript

April 18, 2024 | Market Moving Trends (Ad)

Top 5 AI Stocks to Buy for 2024

March 30, 2024 | seekingalpha.com

Dyadic International, Inc. (DYAI) Q4 2023 Earnings Call Transcript

March 29, 2024 | finance.yahoo.com

Q4 2023 Dyadic International Inc Earnings Call

March 28, 2024 | benzinga.com

Recap: Dyadic International Q4 Earnings

March 28, 2024 | globenewswire.com

Dyadic Reports 2023 Full Year Results and Recent Company Progress

March 28, 2024 | globenewswire.com

Dyadic Announces Change in Board and Management Leadership Roles

April 18, 2024 | Market Moving Trends (Ad)

Top 5 AI Stocks to Buy for 2024

March 27, 2024 | globenewswire.com

Dyadic to Attend Industry Events in April

March 26, 2024 | globenewswire.com

Dyadic Announces Publication of C1 Monoclonal Antibody in Nonhuman Primate Study in Nature Communications

March 21, 2024 | globenewswire.com

Dyadic to Attend Future Food Tech Event March 21 – 22, 2024 in San Francisco, California

March 14, 2024 | globenewswire.com

Dyadic to Report Full Year 2023 Financial Results and Host Conference call on Thursday, March 28, 2024

March 11, 2024 | finance.yahoo.com

Dyadic Announces Closing of Private Placement of $6.0 Million Convertible Notes to Accelerate Near-Term Revenue Growth and Commercialization

March 11, 2024 | globenewswire.com

CORRECTION – Dyadic Announces Closing of Private Placement of $6.0 Million Convertible Notes to Accelerate Near-Term Revenue Growth and Commercialization

March 11, 2024 | globenewswire.com

Dyadic Announces Closing of Private Placement of $6.0 Million Convertible Notes to Accelerate Near-Term Revenue Growth and Commercialization

March 1, 2024 | globenewswire.com

Dyadic to Attend Industry Events in March

February 29, 2024 | ca.finance.yahoo.com

DYAI Aug 2024 2.500 call

February 29, 2024 | ca.finance.yahoo.com

DYAI Apr 2024 2.500 call

February 28, 2024 | msn.com

Dyadic announces strategic partnership agreement to develop rabies vaccines

February 28, 2024 | globenewswire.com

Dyadic Announces Strategic Partnership Agreement to Develop Affordable Rabies Prophylactics and Vaccines Using its Proprietary C1 Cell Microbial Protein Production Platform

February 23, 2024 | globenewswire.com

Dyadic Advances Collaboration with Israel Institute for Biological Research (IIBR) Targeting Bio-Threats and Emerging Disease Solutions

February 21, 2024 | finance.yahoo.com

Dyadic Advances Collaboration with Israel Institute for Biological Research (IIBR) Targeting Bio-Threats and Emerging Disease Solutions

February 21, 2024 | finance.yahoo.com

Dyadic Advances Collaboration with Israel Institute for Biological Research (IIBR) Targeting Bio-Threats and Emerging Disease Solutions

February 21, 2024 | globenewswire.com

Dyadic Advances Collaboration with Israel Institute for Biological Research (IIBR) Targeting Bio-Threats and Emerging Disease Solutions

February 20, 2024 | finance.yahoo.com

DYAI: Catching Up With Dyadic

February 6, 2024 | msn.com

Dyadic signs R&D agreement with global biopharmaceutical company

See More Headlines

Receive DYAI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Dyadic International and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/10/2021
Today: 4/17/2024
Next Earnings (Estimated): 5/08/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Biological products, except diagnostic
Sub-Industry: N/A
Current Symbol: NASDAQ:DYAI
CUSIP: N/A
CIK: 1213809
Web: www.dyadic.com
Phone: (561) 743-8333
Fax: 561-743-8343
Employees: 7
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $6.00
High Stock Price Target: $6.00
Low Stock Price Target: $6.00
Potential Upside/Downside: +257.1%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 1 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($0.24)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-6,800,000.00
Net Margins: -234.39%
Pretax Margin: -234.39%
Return on Equity: -81.57%
Return on Assets: -65.71%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 3.58
Quick Ratio: 3.58

Sales & Book Value

Annual Sales: $2.90 million
Price / Sales: 16.78
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.20 per share
Price / Book: 8.40

Miscellaneous

Outstanding Shares: 28,970,000
Free Float: 21,064,000
Market Cap: $48.67 million
Optionable: Optionable
Beta: 0.60

10 "Recession Proof" Stocks That Will Thrive in Any Market

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

Mr. Mark A. Emalfarb (Age 68)
Founder, CEO, President & Director
Comp: $636.61k
Ms. Ping Wang Rawson CPA (Age 48)
M.B.A., Chief Financial Officer
Comp: $279.07k
Mr. Joseph P. Hazelton
Chief Business Officer
Mr. Doug Pace B.A.
Executive Vice President of Business Development
Ms. Ana Gómez Rodriguez
Secretary of the Board

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

DYAI Stock Analysis - Frequently Asked Questions

Should I buy or sell Dyadic International stock right now?: 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Dyadic International in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" DYAI shares.
View DYAI analyst ratings or view top-rated stocks.
What is Dyadic International's stock price target for 2024?: 1 equities research analysts have issued 12-month price targets for Dyadic International's shares. Their DYAI share price targets range from $6.00 to $6.00. On average, they anticipate the company's stock price to reach $6.00 in the next year. This suggests a possible upside of 257.1% from the stock's current price.
View analysts price targets for DYAI or view top-rated stocks among Wall Street analysts.
How have DYAI shares performed in 2024?: Dyadic International's stock was trading at $1.61 at the start of the year. Since then, DYAI stock has increased by 4.3% and is now trading at $1.68.
View the best growth stocks for 2024 here.
When is Dyadic International's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024.
View our DYAI earnings forecast.

How were Dyadic International's earnings last quarter?: Dyadic International, Inc. (NASDAQ:DYAI) issued its quarterly earnings data on Wednesday, November, 10th. The biotechnology company reported ($0.06) EPS for the quarter, beating analysts' consensus estimates of ($0.09) by $0.03. The biotechnology company earned $0.69 million during the quarter, compared to analyst estimates of $0.61 million. Dyadic International had a negative trailing twelve-month return on equity of 81.57% and a negative net margin of 234.39%. During the same period last year, the firm earned ($0.09) EPS.
What other stocks do shareholders of Dyadic International own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Dyadic International investors own include Silvercorp Metals (SVM), Endeavour Silver (EXK), Hecla Mining (HL), Pfizer (PFE), Advanced Micro Devices (AMD), Endeavour Silver (EDR), Mandalay Resources (MND), Alibaba Group (BABA) and Chimerix (CMRX).
How do I buy shares of Dyadic International?: Shares of DYAI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:DYAI) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Dyadic International (DYAI) Stock Price, News & Analysis

Dyadic International MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Dyadic International Stock (NASDAQ:DYAI)

DYAI Stock Price History

DYAI Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Institutional Ownership

DYAI Stock Analysis - Frequently Asked Questions

Overall MarketRank^™